. 2007 Feb;8(2):136–146. doi: 10.1631/jzus.2007.B0136

Table 1.

Percentage of bone marrow mesenchymal stem cells expressing specific phenotypes

Passage	CD34^**	CD45	CD29	CD44	CD90	CD166	SH2	SH3
Pre-3^*	3.8±5.2^a	5.2±4.7^a	30.2±11.2^a	29.6±7.8^a	37.6±19.2^a	47.5±6.9^a	37.8±5.7^a	27.2±15.2^a
Pre-4	3.8±4.3^a	5.1±3.3^a	24.8±9.2^a	27.4±11.4^a	35.6±10.5^a	48.6±16.2^a	35.8±8.9^a	41.2±14.2^a
Pre-8	2.0±0.9	3.3±1.1^b	57.3±9.4^a	43.5±12.2^a	59.8±12.7^b	75.4±9.5^b	60.4±7.9^a	55.5±11.2^a
Pre-13	1.2±0.5	0.9±0.3	75.2±11.6	81.4±15.7	70.3±14.4	81.5±16.6	83.7±18.2	80.9±12.4
Pre-18	1.1±0.7	0.5±0.3	82.6±10.4	85.8±15.8	80.2±18.6	90.4±14.5	84.2±14.2	82.4±10.8
Post-1	3.3±2.5^a	5.9±6.2^a	27.3±13.0^a	29.1±17.2^a	34.7±9.9^a	50.8±14.6^a	41.4±9.3^a	39.4±11.7^a
Post-5	1.5±0.7	3.6±1.3^a	54.8±8.2^a	46.4±13.3^a	57.2±15.4^b	79.5±12.8^b	62.2±10.2^a	53.9±7.5^a
Post-10	1.7±0.9	1.1±0.6	73.3±16.1	79.6±18.7	68.8±17.3	84.5±20.2	86.4±6.8	82.5±9.3
Post-15	0.9±1.2	0.2±0.5	87.4±7.7	88.3±11.5	81.7±12.5	93.5±10.4	80.1±9.5	79.3±10.4

Pre-: Pre-cryopreservation; Post-: Post-cryopreservation

^**

CD34: Hematopoietic stem cell marker; CD45: Leucocyte common antigen (LCA); CD29: Beta-1 integrin; CD44: Family of cell surface glycoproteins; CD90: Thy-1; CD166: Activated leukocyte cell adhesion molecule (ALCAM); SH2: An Src-homology 2 domain; SH3: An Src-homology 3 domain. CD34⁻, CD45⁻, CD29⁺, CD44⁺, CD90⁺, CD166⁺, SH2⁺ and SH3⁺ are immunophenotypic properties of hMSCs (Pittenger et al., 1999)

Comparison with Post-10 passage: P<0.01

Comparison with Post-10 passage: P<0.05